Call for Abstract

9th Indo Global Summit on Cancer Therapy, will be organized around the theme “Precision therapeutics and curative approaches to curb cancer”

Indo Cancer Summit 2015 is comprised of 12 tracks and 62 sessions designed to offer comprehensive sessions that address current issues in Indo Cancer Summit 2015.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1 Molecular and cellular oncology
  • Track 1-2Cancer Genomics and Systems Biology
  • Track 1-3Tumor microenvironment or tumor immunology and immune therapy
  • Track 1-4 Cancer stem cells
  • Track 1-5 Metabolic complexity of signal transduction
  • Track 1-6 Case study
  • Track 2-1Cancer screening and early detection & prevention
  • Track 2-2 Molecular diagnostics
  • Track 2-3 Personalized genomics and clinical biomarkers
  • Track 2-4 Digital cancer pathology and imaging
  • Track 2-5 Chemotherapy and biological therapeutics
  • Track 2-6 Innovational combinational therapy
  • Track 3-1Functional genomics in drug discovery and development
  • Track 3-2 Therapeutic antibodies and cancer vaccines
  • Track 3-3 Novel drug delivery system and cancer drug designing
  • Track 3-4 Nanotechnology in cancer drugs
  • Track 3-5 Anticancer drugs in global market: economy and their cost effectiveness
  • Track 3-6 Cancer clinical trails
  • Track 3-7Regulatory issues in cancer research
  • Track 4-1Head and neck cancers
  • Track 4-2Gastrointestinal cancers
  • Track 4-3Gynecologic and breast cancers
  • Track 4-4 Hematologic cancers
  • Track 4-5Robotics in oncological Surgery
  • Track 4-6Translational approach in cancer treatment
  • Track 5-1 Current Trends and Innovations in Metabolomics
  • Track 5-2Stem cell mediated immuno gene therapy for tumors
  • Track 5-3 Cancer biomarkers, Diagnostic and Prognostic Cancer Biomarkers
  • Track 5-4Tumour-host interactions,Nuclear responses and tumorigenesis
  • Track 5-5 Challenges and new opportunities with antibody drugs
  • Track 5-6Cancer-induced immunosuppressive cells.
  • Track 6-1Metabolism of carcinogens
  • Track 6-2Biological and external factors for carcinogenesis
  • Track 6-3 Mutagenesis- Directed, Site-Specific and Mismatched
  • Track 6-4Oncogenomics and proteomics
  • Track 6-5Use of proteins as biomarkers and their role in carcinogenesis.
  • Track 6-6The effects of environmental chemical carcinogens
  • Track 7-1Advances in Stage - I
  • Track 7-2Advances in Stage - II
  • Track 7-3Advances in Stage - III
  • Track 7-4Advances in Stage - IV
  • Track 8-1Cancer Chemotherapy
  • Track 8-2Breast Cancer Treatment
  • Track 8-3Advances in Liver Cancer Treatment
  • Track 8-4Advances in Prostate Cancer Treatment
  • Track 9-1Lung Cancer Diagnosis and Treatment
  • Track 9-2Lung Cancer Metastasis
  • Track 9-3Advancements in Lung Cancer
  • Track 9-4Chemo for Lung Cancer
  • Track 10-1Liver Cancer prognosis
  • Track 10-2Brain Cancer prognosis
  • Track 10-3Squamous cell Cancer prognosis
  • Track 10-4Metastatic prognosis
  • Track 11-1Bronchial carcinoma
  • Track 11-2Oat Cell Carcinoma
  • Track 11-3Squamous Cell Carcinoma
  • Track 11-4Lung Carcinoma
  • Track 12-1Ayurveda- Cancer basics & therapeutics
  • Track 12-2Yoga & Naturopathy- cancer basics & therapeutics
  • Track 12-3Unani- Cancer basics & therapeutics
  • Track 12-4Siddha- Cancer basics & therapeutics
  • Track 12-5Homoeopathy- Cancer basics & therapeutics